Although there are no direct studies describing TLR6 activity in animals with PAH, there are strong indirect indications that activation of this receptor promotes vascular proliferation and remodeling, the increase of endothelin-1 levels, and the development of local inflammation in PAH. Here, EDN1 is linked to pulmonary arterial hypertension.